Breaking News
FONT-SIZE Plus   Neg
Share SHARE

AMREP Corp. Slips To Loss In Q3

AMREP Corporation (AMR: Quote) reported Friday a third-quarter net loss of $0.3 million or $0.05 per share, compared to net income of $1.3 million or $0.21 per share last year.

Results for the quarter included a tax benefit of $0.4 million or $0.06 per share, compared to a benefit of $0.8 million or $0.13 per share last year.

Revenues for the quarter declined to $21.4 million from $23.8 million last year.

Click here to receive FREE breaking news email alerts for AMR Corp. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Germany's unemployment increased unexpectedly in August as worsening economic activity weighed on job creation. In addition, consumer price inflation, at a four-and-a-half-year low, boosted the scope for more stimulus from the European Central Bank. The number of people out of work increased by a seasonally adjusted 2,000 persons to 2.901 million in August, the Federal Labor Agency reported. NASA has approved the development of the world's most powerful rocket, designed to take humans beyond Earth orbit and to Mars. NASA officials Wednesday announced they have completed a rigorous review of the Space Launch System (SLS) -- the heavy-lift, exploration class rocket under development - and approved the program's progression from formulation to development, something no other exploration Eurozone economic confidence weakened more-than-expected in August to its lowest level in eight months, underscoring rising pessimism amid heightened geopolitical tensions and stagnating economic recovery. The economic confidence index fell to 100.6 in August, the lowest score since December, from 102.1 in July, the European Commission said Thursday.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.